DK3027063T3 - Opo-glyceridsammensætning - Google Patents

Opo-glyceridsammensætning Download PDF

Info

Publication number
DK3027063T3
DK3027063T3 DK14747618.8T DK14747618T DK3027063T3 DK 3027063 T3 DK3027063 T3 DK 3027063T3 DK 14747618 T DK14747618 T DK 14747618T DK 3027063 T3 DK3027063 T3 DK 3027063T3
Authority
DK
Denmark
Prior art keywords
opo
composition
glyceride
alpha
weight
Prior art date
Application number
DK14747618.8T
Other languages
English (en)
Inventor
Luisa Gambelli
Randolph Happe
Sebastiano Banni
Original Assignee
Bunge Loders Croklaan B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48900910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3027063(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bunge Loders Croklaan B V filed Critical Bunge Loders Croklaan B V
Application granted granted Critical
Publication of DK3027063T3 publication Critical patent/DK3027063T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (7)

1. 1,3-dioleoyl-2-palmitoylglycerid (ΟΡΟ) til anvendelse ved udvikling og/eller forbedring af hjernefunktion, beskyttelse mod neuroinflammation eller behandling og/eller lindring af misbrug eller Alzheimers sygdom.
2. OPO til anvendelse ifølge krav 1, hvor OPO er afledt af en vegetabilsk kilde.
3. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er fremstillet ved omsætning af palmeoliestearin med oliesyre eller en ester deraf i nærvær af en lipase.
4. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form af en sammensætning, som omfatter alpha-linolensyre eller et glycerid deraf i en mængde på mere end 1 vægt-% alpha-linolensyre baseret på de samlede frie og bundne C6-til C24-fedtsyrer og/eller linolsyre eller et glycerid deraf, og hvor vægtforholdet mellem samlet fri og bunden linolsyre og samlet fri og bundet alpha-linolensyre fortrinsvis er 15:1 eller mindre.
5. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form af en blanding omfattende (i) en sammensætning omfattende alpha-linolensyre eller et glycerid deraf og (ii) en triglyceridsammensætning omfattende OPO i en mængde på mindst 20 vægt-%, og hvor sammensætningen omfattende alpha-linolensyre eller et glycerid deraf fortrinsvis er en vegetabilsk olie.
6. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form afen sammensætning, som er uden phospholipider.
7. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form af en sammensætning, som er en modermælkserstatning yderligere omfattende protein, kulhydrat, mineraler og vitaminer.
DK14747618.8T 2013-08-01 2014-07-31 Opo-glyceridsammensætning DK3027063T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13275180 2013-08-01
PCT/EP2014/066549 WO2015014967A1 (en) 2013-08-01 2014-07-31 Glyceride composition

Publications (1)

Publication Number Publication Date
DK3027063T3 true DK3027063T3 (da) 2019-02-18

Family

ID=48900910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14747618.8T DK3027063T3 (da) 2013-08-01 2014-07-31 Opo-glyceridsammensætning

Country Status (7)

Country Link
US (1) US20160166527A1 (da)
EP (1) EP3027063B1 (da)
KR (1) KR20160041952A (da)
CN (1) CN105517452A (da)
DK (1) DK3027063T3 (da)
NZ (1) NZ716341A (da)
WO (1) WO2015014967A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160166527A1 (en) 2013-08-01 2016-06-16 Loders Croklaan B.V. Glyceride Composition
BR112016009351B1 (pt) 2013-11-01 2020-12-22 N.V. Nutricia Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
MY196605A (en) * 2016-12-09 2023-04-20 Nutricia Nv Nutritional Composition for Improving Cell Membranes
CN108265089B (zh) * 2016-12-30 2021-06-11 中粮集团有限公司 一种含有1,3-二油酸-2-棕榈酸甘油三酯的油脂组合物及其制备方法
KR102036556B1 (ko) * 2018-06-26 2019-10-25 주식회사 삼양사 고-올레산 해바라기유의 사용에 의하여 효소적 에스테르화의 효율을 향상시키는 방법
JP6797269B2 (ja) * 2018-11-20 2020-12-09 花王株式会社 油脂組成物
PH12023550062A1 (en) * 2020-07-10 2024-03-18 Bunge Lipid Enzymtec Sdn Bhd Fat composition
WO2022045953A1 (en) * 2020-08-31 2022-03-03 Aak Ab (Publ) A process for production of a vegetable oil composition having at least 50% palmitic acid present in the sn2-position out of total palmitic acid in the triglycerides of the vegetable oil composition
CN112195199A (zh) * 2020-10-29 2021-01-08 赞宇科技集团股份有限公司 一种1，3-二油酸-2-棕榈酸甘油三酯的生产方法
CN113699191A (zh) * 2021-10-19 2021-11-26 江南大学 一种2-花生四烯酸甘油一酯的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
GB2178752B (en) 1985-07-12 1989-10-11 Unilever Plc Substitute milk fat
JP2826808B2 (ja) * 1995-07-14 1998-11-18 カルピス株式会社 脳機能改善、学習能力増強および記憶力増強作用を有する機能性食品
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
IL158554A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
KR101368603B1 (ko) * 2005-04-27 2014-02-27 엔지모테크 리미티드 모유 지방 대체물
KR101126305B1 (ko) * 2005-09-08 2012-03-19 로더스 크로클란 비.브이. 디올레오일 팔미토일 글리세리드 제조 방법
EP1928989B1 (en) * 2005-09-08 2011-11-09 Loders Croklaan B.V. Process for producing triglycerides
ES2671172T3 (es) * 2007-02-28 2018-06-05 Loders Croklaan B.V. Proceso para producir una composición de glicérido
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
MX2010004820A (es) * 2007-11-01 2010-08-10 Enzymotec Ltd Mezcla lipidica para nutricion infantil.
US20160166527A1 (en) 2013-08-01 2016-06-16 Loders Croklaan B.V. Glyceride Composition

Also Published As

Publication number Publication date
EP3027063B1 (en) 2018-11-21
CN105517452A (zh) 2016-04-20
KR20160041952A (ko) 2016-04-18
US20160166527A1 (en) 2016-06-16
EP3027063A1 (en) 2016-06-08
NZ716341A (en) 2018-02-23
WO2015014967A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
EP3027063B1 (en) Opo glyceride composition
Gunstone Movements towards tailor-made fats
US9695384B2 (en) Process for producing a glyceride composition
AU2006288937B2 (en) Process for producing dioleoyl palmitoyl glyceride
DK2956010T3 (da) Fedtsammensætning
US8183021B2 (en) Process for producing triglycerides
DK2219476T3 (da) Modermælkserstatningssammensætning
WO2015050220A1 (ja) 油脂組成物
US7604966B2 (en) Process for the production of structured lipid mixtures
EP2845490A1 (en) Fat composition for improved body fat distribution
AU2015311021B2 (en) Composition
WO2025011791A1 (en) Fat compositions with omega-3 fatty acid residues